OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study
Bowen Tang, Arvid Sjölander, Jonas W. Wastesson, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102689-102689
Closed Access | Times Cited: 11
Bowen Tang, Arvid Sjölander, Jonas W. Wastesson, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102689-102689
Closed Access | Times Cited: 11
Showing 11 citing articles:
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
JAMA Neurology (2025)
Closed Access | Times Cited: 1
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
JAMA Neurology (2025)
Closed Access | Times Cited: 1
Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
Åke Sjöholm, Louise Bennet, Peter M. Nilsson
Scandinavian Journal of Primary Health Care (2025), pp. 1-7
Open Access
Åke Sjöholm, Louise Bennet, Peter M. Nilsson
Scandinavian Journal of Primary Health Care (2025), pp. 1-7
Open Access
Mind the sleep: how does obstructive sleep apnoea syndrome relate to risk of dementia?
Daniil Lisik, Ding Zou
Thorax (2025), pp. thorax-222873
Closed Access
Daniil Lisik, Ding Zou
Thorax (2025), pp. thorax-222873
Closed Access
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Risk of depression and dementia among individuals treated with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists
Osvaldo P. Almeida
Current Opinion in Psychiatry (2025)
Closed Access
Osvaldo P. Almeida
Current Opinion in Psychiatry (2025)
Closed Access
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders
Riccardo De Giorgi, Ana Ghenciulescu, Courtney Yotter, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335593
Closed Access
Riccardo De Giorgi, Ana Ghenciulescu, Courtney Yotter, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335593
Closed Access
Glycated hemoglobin and body mass index as mediators of GLP‐1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4
Martin Schain, Edvin Johansson, Iina Laitinen, et al.
Diabetologia (2025)
Open Access
Martin Schain, Edvin Johansson, Iina Laitinen, et al.
Diabetologia (2025)
Open Access
Recent achievements and future directions of anti-obesity medications
Gerald Grandl, Aaron Novikoff, Xue Liu, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101100-101100
Open Access | Times Cited: 3
Gerald Grandl, Aaron Novikoff, Xue Liu, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101100-101100
Open Access | Times Cited: 3
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists for Dementia Risk: A Real-World Study
Filippos Anagnostakis, Michail Kokkorakis, S. Nagarajan, et al.
(2024)
Closed Access
Filippos Anagnostakis, Michail Kokkorakis, S. Nagarajan, et al.
(2024)
Closed Access
Sodium‐glucose cotransporter‐2 inhibitors use and risk of dementia in different ethnoracial groups with type 2 diabetes
Shu Ching Yang, Wen‐Chieh Liao, Yi‐Sheng Jhang, et al.
Alzheimer s & Dementia (2024)
Open Access
Shu Ching Yang, Wen‐Chieh Liao, Yi‐Sheng Jhang, et al.
Alzheimer s & Dementia (2024)
Open Access
